SCHEMBL20129512

SCHEMBL20129512

c1ccc(-c2ccc3c(c2)c2c4oc5ccccc5c4ccc2n3-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.35
MAPT P10636 7/20 0.33
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
ALOX5 P09917 1/20 0.33
LMNA P02545 4/20 0.33
KDM4E B2RXH2 3/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 4/20 0.33
POLB P06746 2/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PLA2G10 O15496 1/20 0.32
USP2 O75604 1/20 0.32
HTT P42858 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20129509 0.99 TSHR (0.34) TSHRMAPTPLA2G2APLA2G4AALOX5
SCHEMBL23595263 0.95 TSHR (0.34) TSHRMAPTPLA2G2APLA2G4AALOX5
SCHEMBL21365798 0.95 TSHR (0.34) TSHRMAPTPLA2G2APLA2G4AALOX5
SCHEMBL21365793 0.95 TSHR (0.35) TSHRMAPTALOX5LMNAKDM4E
SCHEMBL20129510 0.95 TSHR (0.35) TSHRMAPTPLA2G2APLA2G4AALOX5
SCHEMBL21365801 0.95 TSHR (0.35) TSHRMAPTALOX5LMNAKDM4E
SCHEMBL25133004 0.95 TSHR (0.35) TSHRMAPTPLA2G2APLA2G4AALOX5
SCHEMBL27444632 0.94 TSHR (0.34) TSHRMAPTALOX5LMNAKDM4E
SCHEMBL21365797 0.94 TSHR (0.35) TSHRMAPTPLA2G2APLA2G4ALMNA
SCHEMBL23595265 0.94 TSHR (0.35) TSHRMAPTPLA2G2APLA2G4ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10651396-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same LG DISPLAY CO., LTD. (KR) 2020-05-12 US disclosed
US-20180130953-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-10 US disclosed
US-20180130953-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10651396-B2 Organic compound, and organic light emitting diode and organic light emitting display device including the same AOX1, OCIAD1, OCIAD2 TSHR 4237/4885MAPT 344/4885PLA2G2A 4571/4885
US-20180130953-A1 ORGANIC COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DISPLAY DEVICE INCLUDING THE SAME AOX1, OCIAD1, OCIAD2 TSHR 4237/4885MAPT 344/4885PLA2G2A 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.